Paul K. Audhya - Feb 11, 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Feb 11, 2024
Transactions value $
$0
Form type
4
Date filed
2/13/2024, 09:06 AM
Previous filing
Nov 21, 2023
Next filing
Feb 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Performance Stock Units Award $0 +48.3K $0.00 48.3K Feb 11, 2024 Common Stock 48.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each PSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on January 10, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of Performance Metrics. 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of February 17, 2024, upon Performance Metrics achieved, subject to continued service through each vesting date.